On March 12, 2013 The U.S. Food and Drug Administration (FDA) issued a drug safety warning about the popular oral antibiotic azithromycin, which goes by the trade names Zithromax or Zmax. The FDA warned that azithromycin can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular […]
On March 11, 2013 the journal Cancer, a peer reviewed scientific publication, announced findings from a newly published study showing that aspirin may lower the risk of melanoma among women. The study was an observational trial design, and it looked at the risk of melanoma in nearly 60,000 post-menopausal Caucasian women. The women entering the […]
On February 26, 2013 the U.S. Food and Drug Administration approved a new pill to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause. The new medication goes by the trade name Osphena (chemical name ospemifene), and it is marketed exclusively in the […]
On February 20, 2013 the United States Food and Drug Administration announced an update to its prior warnings about using codeine in children who have undergone surgery for tonsillectomy and/or adenoidectomy. Specifically, the FDA issued a drug safety communication, advising patients that it would require pharmaceutical manufacturers of codeine-containing products to add a black-box warning […]